Park Ha Biological Technology is trading at $2.23, down 8.6%, amid a broadly weaker U.S. market.

  • The S&P 500 is down 0.43%, Nasdaq down 0.60%, and Dow down 0.66%.
  • Elevated oil prices, rising Treasury yields, and geopolitical risk are weighing on risk sentiment.
  • Recent securities-class-action deadline notices remain a negative overhang; no new company-specific announcement directly explaining the September 9, 2026 decline was found.